These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 29098433)

  • 21. Impact of trans-anal versus laparoscopic total mesorectal excision on the surgical and pathologic outcomes of patients with rectal cancer: meta-analysis of randomized controlled trials.
    Farooqi M; Hussain A; Ahmad A; Zaheer Z; Daniyal M; Tahir A; Fatima L; Maham R; Farooqui A; Khan A
    Langenbecks Arch Surg; 2023 Oct; 408(1):413. PubMed ID: 37861749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.
    Zuhdy M; Elmore U; Shams N; Hegazy MAF; Roshdy S; Eldamshety O; Metwally IH; Rosati R
    J Laparoendosc Adv Surg Tech A; 2020 Jul; 30(7):769-776. PubMed ID: 32240035
    [No Abstract]   [Full Text] [Related]  

  • 23. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
    Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
    Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer: A systematic review and meta-analysis.
    Yi Chi Z; Gang O; Xiao Li F; Ya L; Zhijun Z; Yong Gang D; Dan R; Xin L; Yang L; Peng Z; Yi L; Dong L; De Chun Z
    Medicine (Baltimore); 2024 Jan; 103(4):e36859. PubMed ID: 38277570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands: A Propensity Score-Matched Comparison with Conventional Laparoscopic Total Mesorectal Excision.
    Detering R; Roodbeen SX; van Oostendorp SE; Dekker JT; Sietses C; Bemelman WA; Tanis PJ; Hompes R; Tuynman JB;
    J Am Coll Surg; 2019 Mar; 228(3):235-244.e1. PubMed ID: 30639298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short Term Postoperative and Oncological Outcomes of Two-Dimensional Versus Three-Dimensional Laparoscopic Transanal Total Mesorectal Excision of Rectal Cancer.
    Tey HTV; Foo SMJ; Fong SS; Chong CS
    J Laparoendosc Adv Surg Tech A; 2020 Dec; 30(12):1350-1353. PubMed ID: 32522084
    [No Abstract]   [Full Text] [Related]  

  • 27. Our experience with transanal total mesorectal excision (TaTME) procedures in middle and distal rectal tumors.
    Procházka V; Grolich T; Farkašová M; Čan V; Svatoň R; Svoboda M; Ostřížková L; Eid M; Frola L; Bohatá Š; Kala Z
    Rozhl Chir; 2020; 99(3):124-130. PubMed ID: 32349496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trans-anal or trans-abdominal total mesorectal excision? A systematic review and meta-analysis of recent comparative studies on perioperative outcomes and pathological result.
    Lei P; Ruan Y; Yang X; Fang J; Chen T
    Int J Surg; 2018 Dec; 60():113-119. PubMed ID: 30415089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: A case matched study.
    Ye J; Tian Y; Li F; van Oostendorp S; Chai Y; Tuynman J; Tong W
    Eur J Surg Oncol; 2021 May; 47(5):1019-1025. PubMed ID: 33309105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis.
    Zhang X; Gao Y; Dai X; Zhang H; Shang Z; Cai X; Shen T; Cheng X; Yu K; Li Y
    Surg Endosc; 2019 Mar; 33(3):972-985. PubMed ID: 30374790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Serra-Aracil X; Zarate A; Bargalló J; Gonzalez A; Serracant A; Roura J; Delgado S; Mora-López L;
    Br J Surg; 2023 Jan; 110(2):150-158. PubMed ID: 36224406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a systematic review with meta-analysis.
    Jiang HP; Li YS; Wang B; Wang C; Liu F; Shen ZL; Ye YJ; Wang S
    Surg Endosc; 2018 Jun; 32(6):2632-2642. PubMed ID: 29464401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer.
    Zeng Z; Liu Z; Luo S; Liang Z; Huang L; Ruan L; Chen J; Jie H; Liang W; Liu H; Kang L
    Surg Endosc; 2022 Jun; 36(6):3902-3910. PubMed ID: 34448933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term oncological outcomes of transanal versus laparoscopic total mesorectal excision for mid-low rectal cancer: a retrospective analysis of 2502 patients.
    Li Z; Liu H; Luo S; Hou Y; Zhou Y; Zheng X; Zhang X; Huang L; Zeng Z; Kang L
    Int J Surg; 2024 Mar; 110(3):1611-1619. PubMed ID: 38091943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
    D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P
    Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients.
    Mege D; Hain E; Lakkis Z; Maggiori L; Prost À la Denise J; Panis Y
    Colorectal Dis; 2018 Jun; 20(6):O143-O151. PubMed ID: 29693307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peri-operative, oncological and functional outcomes of robotic versus transanal total mesorectal excision in patients with rectal cancer: A systematic review and meta-analysis.
    Mohamedahmed AYY; Zaman S; Wuheb AA; Ismail A; Nnaji M; Alyamani AA; Eltyeb HA; Yassin NA
    Tech Coloproctol; 2024 Jul; 28(1):75. PubMed ID: 38951249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of oncological and functional outcomes and quality of life after transanal or laparoscopic total mesorectal excision for rectal cancer: a systematic review and meta-analysis.
    Alimova I; Chernyshov S; Nagudov M; Rybakov E
    Tech Coloproctol; 2021 Aug; 25(8):901-913. PubMed ID: 34002288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transanal Total Mesorectal Excision Versus Laparoscopic Surgery for Rectal Cancer Receiving Neoadjuvant Chemoradiation: A Matched Case-Control Study.
    Chen CC; Lai YL; Jiang JK; Chu CH; Huang IP; Chen WS; Cheng AY; Yang SH
    Ann Surg Oncol; 2016 Apr; 23(4):1169-76. PubMed ID: 26597369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer.
    de Lacy FB; van Laarhoven JJEM; Pena R; Arroyave MC; Bravo R; Cuatrecasas M; Lacy AM
    Surg Endosc; 2018 May; 32(5):2442-2447. PubMed ID: 29101570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.